Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Vaccine Spray May Not Protect Kids From Swine Flu

November 7, 2014 9:11 am | by Mike Stobbe - AP Medical Writer | News | Comments

The nasal spray version of the flu vaccine did not protect young children against swine flu last winter and might not work again this year. Read more...                  

TOPICS:

Actinium's AML Drug Gets Positive Study Results

November 6, 2014 2:57 pm | News | Comments

Actinium Pharmaceuticals announced positive data from its ongoing AML drug treatment study. Read more...                          

TOPICS:

Janssen To Collaborate On Multi-Drug Resistant TB Treatment

November 6, 2014 2:41 pm | News | Comments

Janssen announces collaborative evaluation over multi-drug resistant tuberculosis treatment. Read more...                          

TOPICS:
Advertisement

Researchers Use Ultrasound, Bubbles to Improve Stroke Treatment

November 6, 2014 2:25 pm | News | Comments

They are building an entire technology around tiny, microscopic bubbles – a technology that has the potential to play an important role in diagnosing as well as treating disease like stroke and cancer. Read more...        

TOPICS:

Skin Disease Drug Wins European Approval

November 6, 2014 1:57 pm | News | Comments

A synthetic hormone developed more than two decades ago by faculty at the University of Arizona Cancer Center and the UA’s Colleges of Medicine and Science has been approved for patients in Europe. Read more...         

TOPICS:

Gilead Submits Application for New HIV Pill to FDA

November 6, 2014 1:38 pm | News | Comments

Gilead submitted a new drug application that focuses on an experimental HIV pill. Read more...                                

TOPICS:

Funding Speeds Drugs Identification For Alzheimers Prevention

November 6, 2014 1:13 pm | News | Comments

The National Institutes of Health has boosted funding for the first large-scale clinical trial aimed at identifying drugs to stop or slow Alzheimer’s disease in people destined to get the debilitating illness. Read more...       

TOPICS:

Ebola Health Lessons: A Wake-up Call

November 6, 2014 12:02 pm | by Stephanie Guzowski, Editor | Articles | Comments

After months of delayed, fragmented responses, the international medical community recognized Ebola as a threat to global health security. Here’s where the situation stands today as well as questions raised and lessons learned. Read more… 

TOPICS:
Advertisement

Creation of Montreal Pharma Company for $6.4M

November 6, 2014 9:49 am | News | Comments

The IRCM just signed an agreement with a leading international investment firm, Sanderling Ventures, to create Liphorus Pharmaceuticals. Up to $6.4 million will be invested in the new spinoff company in the coming years. Read more...

TOPICS:

Generic Prilosec Gets Final ANDA Approval

November 6, 2014 9:44 am | News | Comments

Glenmark Generics Inc. USA, has been granted final approval for its abbreviated new drug application (ANDA) from the FDA for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca. Read more...

TOPICS:

New Drug Inhibits Cancer Tumor Growth

November 6, 2014 9:38 am | News | Comments

Manchester scientists have shown that a new drug inhibits the growth of tumors in the lab and that its effectiveness is improved by combining it with radiotherapy – suggesting a new approach that could be used in the clinic. Read more...

TOPICS:

FDA Approves Janssen's Hep C Drug

November 6, 2014 9:26 am | News | Comments

Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced the U.S. Food and Drug Administration (FDA) has approved Olysio(simeprevir), a hepatitis C virus (HCV) NS3/4A protease inhibitor, in combination with sofosbuvir as an all-oral, interferon- and ribavirin-free treatment option for genotype 1 chronic hepatitis C (CHC) infection in adult patients. Read more...

TOPICS:

Perrigo Acquires Omega Pharma for $4.5B

November 6, 2014 9:12 am | News | Comments

Perrigo Company plc, a leading global provider of "Quality Affordable Healthcare Products," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe, headquartered in Nazareth, Belgium, announced that they have entered into a definitive agreement with Perrigo. Read more...

TOPICS:

Allergan Deal Inches Forward with Court's Decision

November 5, 2014 2:26 pm | News | Comments

In a win for Valeant and Pershing Square, a federal judge has decided that they can vote in takeover target Allergan's upcoming shareholder meeting. Read more...

TOPICS:

Roche to Invest $470M on Diagnostics

November 5, 2014 2:14 pm | News | Comments

Roche announced it will invest 450 million Swiss Francs ($470 million) over the next three years to establish a new diagnostic manufacturing facility at the Suzhou Industrial Park, in Suzhou, China. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading